Docusign (NASDAQ:DOCU) CRO Paula Hansen Sells 6,000 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $273,240.00. Following the completion of the transaction, the executive owned 89,972 shares of the company’s stock, valued at approximately $4,097,324.88. This represents a 6.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Trading Up 3.6%

Docusign stock opened at $46.02 on Thursday. Docusign Inc. has a 1-year low of $40.16 and a 1-year high of $86.65. The firm has a market capitalization of $8.79 billion, a PE ratio of 29.88, a price-to-earnings-growth ratio of 1.31 and a beta of 0.90. The firm’s 50 day simple moving average is $46.93 and its 200 day simple moving average is $51.11.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.99 by $0.10. The firm had revenue of $830.24 million during the quarter, compared to the consensus estimate of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the company posted $0.90 EPS. Research analysts forecast that Docusign Inc. will post 2.03 earnings per share for the current year.

Docusign announced that its board has authorized a stock repurchase program on Tuesday, March 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Robert W. Baird decreased their target price on shares of Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a research report on Friday, June 5th. Morgan Stanley cut their price target on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a report on Wednesday, March 18th. Royal Bank Of Canada lowered their price objective on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research note on Wednesday, March 18th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Docusign currently has an average rating of “Hold” and a consensus target price of $60.27.

Institutional Trading of Docusign

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Pacer Advisors Inc. boosted its stake in Docusign by 43.2% in the 1st quarter. Pacer Advisors Inc. now owns 1,092,037 shares of the company’s stock worth $51,773,000 after purchasing an additional 329,403 shares in the last quarter. Parallel Advisors LLC increased its stake in Docusign by 113.2% during the 1st quarter. Parallel Advisors LLC now owns 4,568 shares of the company’s stock valued at $217,000 after purchasing an additional 2,425 shares in the last quarter. NewEdge Advisors LLC increased its stake in Docusign by 3.1% during the 1st quarter. NewEdge Advisors LLC now owns 11,024 shares of the company’s stock valued at $523,000 after purchasing an additional 328 shares in the last quarter. Caerus Investment Advisors LLC purchased a new position in Docusign in the first quarter worth about $436,000. Finally, Glenmede Trust Co. NA raised its holdings in Docusign by 11.0% in the first quarter. Glenmede Trust Co. NA now owns 512,593 shares of the company’s stock worth $24,302,000 after buying an additional 50,855 shares during the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.